Testosterone

Active pharmaceutical substance formulated in Jan Aushadhi generic products for Women's Health & Hormones treatment.

🧴 Clinical Application

For Deep Intramuscular (IM) injection ONLY: 250 mg deep IM into the gluteal muscle every 2 to 4 weeks for replacement therapy, administered strictly by a healthcare professional. Never administer intravenously. Periodic monitoring of serum total testosterone, hematocrit/hemoglobin, lipid profile, and prostate-specific antigen (PSA) is mandatory.

⚠️ Side Effects

Common: Polycythemia (elevated hematocrit), injection site soreness, acne, gynecomastia, fluid retention/edema, increased libido, and aggressive mood changes. Rare/Severe: Venous thromboembolism (DVT/PE), worsening sleep apnea, hepatotoxicity, prostatic hypertrophy/progression of latent prostate cancer, and cardiovascular events.

🛡️ Safety Warnings

Black Box Warning: Secondary exposure risk in women and children; polycythemia and cardiovascular risks. Strictly contraindicated in suspected or confirmed carcinoma of the prostate or male breast, pregnancy (teratogenic), severe congestive heart failure, and severe hepatic/renal disease. Hematocrit >54% requires dose withholding or therapeutic phlebotomy.